Clinical Trials

Accrual Status
Limit to SWOG Trials

1028 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Open S2209 VRd-Lite versus DRd followedby Len+/-Dara 5/30/2023 4%
    Open S2210 Targeted Neoadjuvant Treatment for Patients with Localized Prostate Cancer and Germline DNA Repair Deficiency 8/14/2023 2%
    Open S2212 SCARLET 7/21/2023 5%
    Open S2213 A Phase III, Randomized Study of Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone (Dara-VCD) Induction Followed by Autologous Stem Cell Transplant or Dara-VCD Consolidation and Daratumumab… 12/1/2023 0%
    Open S2302 PRAGMATICA - LUNG 3/6/2023 66%
    Open S2303 Adding Nivolumab to Usual Treatment for People with Advanced Stomach or Esophageal Cancer 5/6/2024 0%
    Open S9808 Admin. protocol 6/15/1998
    Open SLA01 IMMUNE CHECKPOINTS IN GASTRIC CANCER FROM LATIN AMERICAN COUNTRIES 0%
    Closed S0000 SELECT (Selenium and Vitamin E Cancer Prevention Trial) 7/25/2001 6/24/2004 100% Published
    Closed S0000A PREADVISE 5/17/2002 9/30/2009 72% Published
    Closed S0000B SELECT Eye Endpoints (SEE) 7/1/2004 7/31/2015 Published
    Closed S0000C RAS 6/4/2004 5/1/2007 94% Published
    Closed S0000D Adenomatous Colorectal Polyps (ACP) 6/3/2008 5/28/2013 100% Published
    Closed S0001 Glioblastoma Multiforme/Gliosarcoma 9/1/2001 11/15/2005 46% Published
    Closed S0002 Smoking Cessation Stage I & II NSCLC 1/1/2002 1/1/2004 2%
    Closed S0003 Carbo/Pac + Tirapazamine vs. Carbo/Pac in Adv. NSCLC; Selected IIIB & IV 11/15/2000 11/15/2002 72% Published
    Closed S0004 Tirapazamine/Cis/Etopo/RT in Limited SCLC 10/15/2000 4/1/2002 60% Published
    Closed S0007 Advanced, Recurrent, or Metastatic 11/1/2000 5/15/2003 100% Published
    Closed S0008 High Dose IFN vs. Cis/Vinblastine/DTIC + IL-2 & IFN in High Risk Melanoma 8/1/2000 11/15/2007 90% Published
    Closed S0009 OVARIAN 3/15/2001 2/1/2006 100% Published
    Scroll Table